Cargando…
Determinants for Simultaneous Binding of Copper and Platinum to Human Chaperone Atox1: Hitchhiking not Hijacking
Cisplatin (CisPt) is an anticancer agent that has been used for decades to treat a variety of cancers. CisPt treatment causes many side effects due to interactions with proteins that detoxify the drug before reaching the DNA. One key player in CisPt resistance is the cellular copper-transport system...
Autores principales: | Palm-Espling, Maria E., Andersson, C. David, Björn, Erik, Linusson, Anna, Wittung-Stafshede, Pernilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728025/ https://www.ncbi.nlm.nih.gov/pubmed/23936210 http://dx.doi.org/10.1371/journal.pone.0070473 |
Ejemplares similares
-
Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer
por: Blockhuys, Stéphanie, et al.
Publicado: (2020) -
Copper Chaperone Atox1 Interacts with Cell Cycle Proteins
por: Matson Dzebo, Maria, et al.
Publicado: (2018) -
Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
por: Öhrvik, Helena, et al.
Publicado: (2015) -
Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration
por: Blockhuys, Stéphanie, et al.
Publicado: (2020) -
The C-Terminus of Human Copper Importer Ctr1 Acts as a Binding Site and Transfers Copper to Atox1
por: Kahra, Dana, et al.
Publicado: (2016)